Inhibitory immune checkpoint (ICP) molecules are pivotal in inhibiting innate and acquired
antitumor immune responses, a mechanism frequently exploited by cancer cells to evade …

Chemotherapy-related cardiac dysfunction, also known as cardiotoxicity, is a group of drug-
related adverse events negatively affecting myocardial structure and functions in patients …

Background In recent years, significant progress has been made in immune checkpoint
inhibitors (ICIs). However, accompanied by remarkable efficacy, a growing number of …

Background EBV produces miRNAs with important functions in cancer growth, tumor
invasion and host immune surveillance. The discovery of EBV miR-BARTs is recent, and …

Epstein-Barr virus (EBV) is associated with various types of human malignancies and with
programmed death ligand (PD-L) 1 expression in neoplastic cells. However, in EBV …

Gastric cancer (GC) is a deadly disease with poor prognosis that is characterized by
heterogeneity. New classifications based on histologic features, genotypes, and molecular …

Immunotherapy represents a promising treatment strategy for targeting various tumor types.
However, the overall response rate is low due to the tumor microenvironment (TME). In the …

Epstein‐Barr virus (EBV) causes malignant carcinomas including B cell lymphomas
accompanied by the systemic inflammation. Previously, we observed that …

Simple Summary Around 50% of all cancer patients receive radiotherapy as part of their
treatment. Recently immunotherapy has shown promising results and become established …

To investigate the cellular and molecular mechanisms associated with targeting CD30-
expressing Hodgkin lymphoma (HL) and immune checkpoint modulation induced by …